Xia Mao

Statistics

Publications

Citations

1.4K

H-Index

Active since

2012

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Hubei Provincial Center for Disease Control and Prevention

Wuhan University of Science and Technology

Wuhan Institute of Bioengineering

Xia Mao is an author at Huazhong University of Science and Technology specializing in chimeric antigen receptor t-cell therapy, immunotherapy, and oncology.

ORCID

Publications per year

2012–2023

Publications

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Na Wang, Xuelian Hu, Wenyue Cao et al. · Blood · 2019 · 264 citations · Full text

Medicine, Hematology, Immunology +12

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma

Di Wang, Jue Wang, Guang Hu et al. · Blood · 2021 · 210 citations · Full text

Medicine, Oncology, Cancer Pharmacology +10

Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia

Liang Huang, Dan Liu, Na Wang et al. · Cell Research · 2017 · 98 citations · Full text

Medicine, Genetics, Molecular Biology +12

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

Hui Luo, Na Wang, Liang Huang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 73 citations · Full text

Life Sciences, Immunology, Oncology +17

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

Chunrui Li, Wenyue Cao, Yimei Que et al. · Clinical and Translational Medicine · 2021 · 69 citations · Full text

Medicine, Hematology, Oncology +16

1–5 of 29